基础医学与临床 ›› 2014, Vol. 34 ›› Issue (2): 226-228.

• 研究论文 • 上一篇    下一篇

调整紫杉醇化疗预处理方案的临床观察

马守东1,肖建波2,李海丽2,王钧2,刘金慧2,王轶楠2   

  1. 1. 唐山市人民医院/肿瘤医院
    2. 唐山市人民医院
  • 收稿日期:2013-04-15 修回日期:2013-07-22 出版日期:2014-02-05 发布日期:2014-01-13
  • 通讯作者: 马守东 E-mail:tsmsd@sina.com

Clinical observation of paclitaxel chemotherapy by premedication procedure adjusted

  • Received:2013-04-15 Revised:2013-07-22 Online:2014-02-05 Published:2014-01-13
  • Contact: Shoudong Ma E-mail:tsmsd@sina.com

摘要: 目的 观察不同紫杉醇预处理方案化疗的用药安全性和不良反应,探索新的紫杉醇化疗预处理方案 方法 紫杉醇 135~175mg/m2,联合铂类药物,21d/周期,输注紫杉醇前用2种预处理方案,比较应用2种预处理方案化疗的不良反应 结果 77例应用调整预处理方案的患者与78例标准预处理方案患者的急性过敏反应、神经毒性、胃肠道反应发生率比较均无差异 结论 调整后的紫杉醇预处理方案安全、有效,与标准预处理方案比较无差异。

关键词: 紫杉醇, 预处理方案

Abstract: Objective To observe the drug safety and adverse reactions of the different paclitaxel premedication, explore a new paclitaxel premedication procedure Methods Two kinds of the premedication procedure be used before injection of paclitaxel, one in standard premedication procedure, the other in adjusted premedication procedure, observe the drug safety and adverse reactions of the different paclitaxel premedication procedure, then explore a new paclitaxel premedication procedure Results The acute allergic reaction, neurotoxicity, gastrointestinal reaction rates were not statistically significant between 77 cases in application of adjustment premedication procedure and 78 cases in standard premedication procedure Conclusion The adjusted paclitaxel premedication procedure is safety, effective.

Key words: paclitaxel, premedication procedure

中图分类号: